Price T Rowe Associates Inc Catabasis Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
N/A
-71,800 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
N/A
-1,429 Reduced 1.95%
71,800 $151,000
Q1 2021

May 17, 2021
BUY
N/A
73,229 New
73,229 $212,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email